We care for your cells
Stem Genomics provides a new test to assess the genomic integrity of stem cells. This innovative test is done using the supernatant collected from your cell cultures that has been shipped at room temperature.
This rapid, sensitive, conclusive and cost-effective test allows the routine monitoring of the genomic integrity of cultured pluripotent stem cells.
Stem Genomics develops a technology invented by Prof John De Vos and Dr Said Assou, researchers at the Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, and co-founders of the company. Located at the heart of the University Hospital Centre of Montpellier, IRMB houses research groups working on basic stem cell research and on innovative applications for regenerative therapy, with the aim of facilitating the transfer from research to clinical applications. Stem Genomics is located at the IRMB Cyborg business incubator and works in close collaboration with IRMB researchers. Stem Genomics has emerged from a prestigious scientific environment.
They trust us
discover and share